Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2015 May 21;3(3):e00513-15. doi: 10.1128/genomeA.00513-15

Draft Genome Sequence of New Leprosy Agent Mycobacterium lepromatosis

Xiang Y Han a,, Nipun A Mistry b, Erika J Thompson c, Hong-Li Tang c, Kanhav Khanna c, Li Zhang b
PMCID: PMC4440969  PMID: 25999555

Abstract

Mycobacterium lepromatosis is a newly discovered cause of leprosy. Here, we present a near-complete genome of M. lepromatosis from strain FJ924 obtained from a patient who died of leprosy. The genome contained 3,215,823 nucleotides and matched ~87% with the Mycobacterium leprae genome. This genome is likely the smallest of all mycobacterial genomes known to date.

GENOME ANNOUNCEMENT

Leprosy is caused by the well-known Mycobacterium leprae (1) and the newly discovered Mycobacterium lepromatosis (2). The bacilli differed at least 9.1% and diverged ~10 million years ago from their last common ancestor (3, 4). This difference contrasts with the clonal nature of worldwide M. leprae strains (57). Several studies have shown that M. lepromatosis is the long-elusive second agent of leprosy (814). The organism has been identified so far in leprosy patients from Mexico (810), Canada (11), Brazil (12), Burma (12), and Singapore (13). It is likely the dominant cause of leprosy in Mexico (9). Dual infections with both M. lepromatosis and M. leprae have been described (8, 12, 13). Like M. leprae, M. lepromatosis has not been cultivated in medium so far.

The present draft genome of M. lepromatosis was sequenced from strain FJ924 that was purified and enriched initially from autopsy liver tissue (2, 3). Due to exhaustions of the fresh organism and extracted DNA, the sequenced DNA was extracted from scraped bacilli on a glass slide smear that had been dried, stained (Kinyoun method), and archived for 6 years. The extraction yielded ~3 ng DNA by use of the QIAamp kit (Qiagen, Valencia, CA). A whole-genome library was then constructed using the KAPA kit (Kapa Biosystems, Wilmington, MA), enriched by six PCR cycles, and sequenced on the HiSeq 2000 sequencer (Illumina, San Diego, CA).

Sixty-nine million reads with paired ends were generated. The reads were filtered to remove human sequences (14 million, ~20%) and matched to the closest M. leprae Br4923 genome (5) with BLAST v2.2.26 (14) for enrichment and removal of contaminant bacterial DNA. The matched reads (11 million) were assembled de novo (Velvet v1.2.10) (15); the contigs were aligned manually and through use of Bowtie 2 v2.1.0 (16) to the M. leprae genome for orders, orientations, and gap closure. A tentative draft genome resulted, which was refined through GapFiller v1-10 (BaseClear BV, Leiden, The Netherlands) (17) to capture unique sequences from all the 69 million reads. Eventually, a draft genome consisting of 3,215,823 nucleotides from 39 final contigs was obtained. From the 11.5 million mapped reads, 500-fold coverage of the genome was achieved. As a quality indicator, the genome contained all 20 genes and pseudogenes (22,814-bp) that were sequenced previously from the same strain (3). This assessment and the low number of gaps hinted that this draft genome was nearly complete.

This M. lepromatosis genome matched ~87% overall with the M. leprae genome (3,268,071 nucleotides) (4, 5). Being also 52 kb (~1.6%) smaller, it was likely the smallest of all mycobacterial genomes known to date. This genome should complement another draft M. lepromatosis genome (3,206,741 nucleotides of 126 contigs) reported several weeks earlier by a separate team (18). Decoding the genome of M. lepromatosis should be useful for the research and care for leprosy.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. LAWX00000000. The version described in this paper is version LAWX01000000.

ACKNOWLEDGMENTS

This work was supported in part by a University Cancer Foundation grant from the University of Texas M. D. Anderson Cancer Center, by the National Institutes of Health (NIH) grant P30 CA016672 for M. D. Anderson’s core Sequencing and Microarray Facility and core Bioinformatics Shared Resource, by the NIH grant CA143883 for M. D. Anderson’s TCGA Genome Data Analysis Center, and by the Mary K. Chapman Foundation.

We disclose no conflicts of interest.

Footnotes

Citation Han XY, Mistry NA, Thompson EJ, Tang H-L, Khanna K, Zhang L. 2015. Draft genome sequence of new leprosy agent Mycobacterium lepromatosis. Genome Announc 3(3):e00513-15. doi:10.1128/genomeA.00513-15.

REFERENCES

  • 1.Hansen GHA. 1874. Undersøgelser Angående Spedalskhedens Årsager (On the etiology of leprosy). Norsk Mag Laegervidenskaben 4:1–88 (In Norwegian.) [Google Scholar]
  • 2.Han XY, Seo Y-H, Sizer KC, Schoberle T, May GS, Spencer JS, Li W, Nair RG. 2008. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 130:856–864. doi: 10.1309/AJCPP72FJZZRRVMM. [DOI] [PubMed] [Google Scholar]
  • 3.Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, Gómez-Valero L, Silva FJ. 2009. Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J Bacteriol 191:6067–6074. doi: 10.1128/JB.00762-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Han XY, Silva FJ. 2014. On the age of leprosy. PLoS Negl Trop Dis 8:e2544. doi: 10.1371/journal.pntd.0002544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007–1011. doi: 10.1038/35059006. [DOI] [PubMed] [Google Scholar]
  • 6.Monot M, Honoré N, Garnier T, Zidane N, Sherafi D, Paniz-Mondolfi A, Matsuoka M, Taylor GM, Donoghue HD, Bouwman A, Mays S, Watson C, Lockwood D, Khamesipour A, Dowlati Y, Jianping S, Rea TH, Vera-Cabrera L, Stefani MM, Banu S, Macdonald M, Sapkota BR, Spencer JS, Thomas J, Harshman K, Singh P, Busso P, Gattiker A, Rougemont J, Brennan PJ, Cole ST. 2009. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 41:1282–1289. doi: 10.1038/ng.477. [DOI] [PubMed] [Google Scholar]
  • 7.Schuenemann VJ, Singh P, Mendum TA, Krause-Kyora B, Jäger G, Bos KI, Herbig A, Economou C, Benjak A, Busso P, Nebel A, Boldsen JL, Kjellström A, Wu H, Stewart GR, Taylor GM, Bauer P, Lee OY, Wu HH, Minnikin DE, Besra GS, Tucker K, Roffey S, Sow SO, Cole ST, Nieselt K, Krause J. 2013. Genome-wide comparison of medieval and modern Mycobacterium leprae. Science 341:179–183. doi: 10.1126/science.1238286. [DOI] [PubMed] [Google Scholar]
  • 8.Han XY, Sizer KC, Velarde-Félix JS, Frias-Castro LO, Vargas-Ocampo F. 2012. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol 51:952–959. doi: 10.1111/j.1365-4632.2011.05414.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vera-Cabrera L, Escalante-Fuentes WG, Gomez-Flores M, Ocampo-Candiani J, Busso P, Singh P, Cole ST. 2011. A case of diffuse lepromatous leprosy associated with “Mycobacterium lepromatosis.” J Clin Microbiol 49:4366–4368. doi: 10.1128/JCM.05634-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Han XY, Jessurun J. 2013. Severe leprosy reactions due to Mycobacterium lepromatosis. Am J Med Sci 345:65–69. doi: 10.1097/MAJ.0b013e31826af5fb. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jessamine PG, Desjardins M, Gillis T, Scollard D, Jamieson F, Broukhanski G, Chedore P, McCarthy A. 2012. Leprosy-like illness in a patient with Mycobacterium lepromatosis from Ontario, Canada. J Drugs Dermatol 11:229–233. [PubMed] [Google Scholar]
  • 12.Han XY, Aung FM, Choon S-E, Werner B. 2014. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries. Am J Clin Pathol 142:524–532. doi: 10.1309/AJCP1GLCBE5CDZRM. [DOI] [PubMed] [Google Scholar]
  • 13.Han XY, Sizer KC, Tan HH. 2012. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. J Drugs Dermatol 11:168–172. [PubMed] [Google Scholar]
  • 14.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  • 15.Zerbino DR. 1 September 2010. Using the velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics. Chapter 11:Unit 11.5. doi: 10.1002/0471250953.bi1105s31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Boetzer M, Pirovano W. 2012. Toward almost closed genomes with GapFiller. Genome Biol 13:R56. doi: 10.1186/gb-2012-13-6-r56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Singh P, Benjak A, Schuenemann VJ, Herbig A, Avanzi C, Busso P, Nieselt K, Krause J, Vera-Cabrera L, Cole ST. 2015. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis. Proc Natl Acad Sci U S A 112:4459–4464. doi: 10.1073/pnas.1421504112. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES